News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
PharmaSGP Holding SE proposes a significant increase in dividend to EUR 1.36 per share for 2023, totaling EUR 16,320,000.00. The company plans to adjust its dividend policy for future distributions -
-
-
COMMUNIQUÉ DE PRESSE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP surpasses €100 million revenues in 2023, plans growth in 2024. Achieved 17.8% revenue increase and 20.8% rise in adjusted EBITDA. Forecasts €107-112 million revenues and €35-38 million EBITDA for 2024